Skip to main content
Signal8

DAVION HEALTHCARE PLC (DAVI)

Davion Healthcare Plc is an Irish public limited company that develops and commercializes non-invasive home tests for the early detection of health anomalies, including cancers. Its products use thermography: a liquid crystal film placed on the skin shows temperature differences as color shifts, and AI analysis of smartphone images interprets the result. It has four completed tests, BreastCheck, FootFlow (diabetic circulation), Testic and ThermaDerm, all non-diagnostic Class I devices. BreastCheck and FootFlow have been FDA-registered, and registered in the EU and UK, since November 2023. Davion operates a licensing model and has a global manufacturing and distribution agreement for BreastCheck with NeuRX Health Inc., which provides $120 million in staged license fees and minimum annual royalties of $10 million over an initial ten-year term. The company was incorporated in Cyprus in 2022 and re-domiciled to Ireland in 2024, keeping a wholly owned Cyprus subsidiary. It plans to pair product commercialization with acquisitions of complementary healthcare businesses, and has launched a £30 million five-year senior secured bond through Davion Healthcare Finance Ltd. The listing is a direct listing of 25,000,000 existing ordinary shares, with no new capital raised.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

Davion Healthcare Plc logo

Davion Healthcare Plc

NASDAQ:DAVIHealthcare
+0.98%$1.03
CLOSED
AH$1.04+0.97%vs close
Mkt Cap$25.75M
EV-
Float13.48M
O/S25M
VOL186K sh
$ Vol$192K
RVOL0.14×
Inst Own-
SI4.6%
Net Cash/Sh-
Dilution
Davion Healthcare Plc logoNASDAQ:DAVIClosed$1.03+0.98%

DAVION HEALTHCARE PLC (DAVI) dilution facts from SEC filings

Snapshot as of Dec 31, 2025, built from 18 SEC filings.

Shelf registration
None on file in the filings reviewed
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
1 warrant series recorded as outstanding
Most recent offering
PIPE, closed Mar 10, 2026
Source: 20-F filed Apr 30, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro